References of "Current Opinion in Hematology"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailHematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission
Baron, Frédéric ULg; Storb, R.

in Current Opinion in Hematology (2007), 14(2), 145-151

Purpose of review Allogeneic hematopoietic cell transplantation with myeloablative conditioning is a well established therapy for patients with acute myeloid leukemia. Its efficacy depends, in part, on ... [more ▼]

Purpose of review Allogeneic hematopoietic cell transplantation with myeloablative conditioning is a well established therapy for patients with acute myeloid leukemia. Its efficacy depends, in part, on the destruction of recipient acute myeloid leukemia cells by the conditioning regimen and, in part on their removal by donor immune cells contained in the graft (graft-versus-tumor effect). Due to regiment related toxicities, the use of myeloablative allogeneic hematopoietic cell transplantation has been restricted to younger patients in good condition. More recently, the introduction of allogeneic hematopoietic cell transplantation following reduced-intensity or nonmyeloablative conditioning regimens, which rely mainly on graft-versus-tumor effects for tumor cell eradication, has permitted extending hematopoietic cell transplantation to include older patients and those with medical comorbidities. Recent findings Early results with allogeneic hematopoietic cell transplantation after nonmyeloablative and reduced-intensity conditioning for patients with acute myeloid leukemia in first complete remission are encouraging, with 2-year survivals after hematopoietic cell transplantation ranging from 48 to 79% among studies. Further, retrospective studies have demonstrated similar outcomes in adult patients with acute myeloid leukemia in complete remission given either myeloablative or nonmyeloablative conditioning. Summary Prospective studies are needed to define the place of allogeneic hematopoietic cell transplantation after nonmyeloablative or reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission, and to determine a role for consolidation chemotherapy before hematopoietic cell transplantation, if any. [less ▲]

Detailed reference viewed: 335 (1 ULg)
Full Text
See detailCurrent status of hematopoietic stem cell transplantation after nonmyeloablative conditioning
Baron, Frédéric ULg; Sandmaier, B. M.

in Current Opinion in Hematology (2005), 12(6), 435-443

Detailed reference viewed: 4 (3 ULg)